Literature DB >> 19835469

Heparanase expression of glioma in human and animal models.

Xin Hong1, Kevin K Nelson, Ana C deCarvalho, Steven N Kalkanis.   

Abstract

OBJECT: Mammalian heparanase has been shown to function in tumor progression, invasion, and angiogenesis. However, heparanase expression in gliomas has not been well analyzed. To clarify its expression in gliomas, human glioma tissues and glioma animal models were investigated.
METHODS: The expression of heparanase mRNA was determined in 33 resected human glioma tissues by semiquantitative real-time polymerase chain reaction. Heparanase expression was verified with a Western blot assay and immunohistochemistry (IHC) staining. Primary neurospheres from human glioblastoma multiforme (GBM) were developed in vitro. Heparanase expression in murine astrocytoma and human primary neurosphere animal models was examined using IHC.
RESULTS: The authors found that heparanase mRNA is greatly increased in gliomas including oligodendroglioma (9 samples), anaplastic astrocytoma (11 samples), and GBM (13 samples) as compared with healthy brain mRNA (3 samples). Note, however, that no significant difference was observed among the 3 tumor groups. Increased heparanase expression was also found in tumor tissues on Western blotting. Immunohistochemistry staining demonstrated that heparanase was expressed by neovessel endothelial cells, infiltrated neutrophils, and in some cases, by neoplastic cells. Heparanase-expressing cells, including GBM tumor cells and neovessel endothelial cells, exhibited decreased expression of CD44, a cell adhesion molecule on the cell membrane that is important for regulating tumor invasion. In addition, heparanase-expressing tumor cells showed an elevated density of the cell proliferation marker Ki 67, as compared with its density in non-heparanase-expressing tumor cells, suggesting that heparanase expression is correlated with enhanced tumor proliferation. Two animal glioma models were tested for heparanase expression. Both murine astrocytoma cells (Ast11.9-2) and cultured primary human GBM neurospheres expressed heparanase when grown in animal brain tissue.
CONCLUSIONS: Glioma tissues contain increased levels of heparanase. Multiple cell types contribute to the expression of heparanase, including neovessel endothelial cells, tumor cells, and infiltrated neutrophils. Heparanase plays an important role in the control of cell proliferation and invasion. Animal models using Ast11.9-2 and primary neurospheres are suitable for antitumor studies targeting heparanase.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19835469     DOI: 10.3171/2009.9.JNS09682

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  6 in total

1.  Heparan Sulfate Glycosaminoglycans in Glioblastoma Promote Tumor Invasion.

Authors:  Vy M Tran; Anna Wade; Andrew McKinney; Katharine Chen; Olle R Lindberg; Jane R Engler; Anders I Persson; Joanna J Phillips
Journal:  Mol Cancer Res       Date:  2017-08-04       Impact factor: 5.852

Review 2.  Glycosylation alterations in lung and brain cancer.

Authors:  Hassan Lemjabbar-Alaoui; Andrew McKinney; Yi-Wei Yang; Vy M Tran; Joanna J Phillips
Journal:  Adv Cancer Res       Date:  2015-02-07       Impact factor: 6.242

Review 3.  Heparanase regulation of cancer, autophagy and inflammation: new mechanisms and targets for therapy.

Authors:  Ralph D Sanderson; Michael Elkin; Alan C Rapraeger; Neta Ilan; Israel Vlodavsky
Journal:  FEBS J       Date:  2016-11-16       Impact factor: 5.542

4.  Novel therapeutic targets in the brain tumor microenvironment.

Authors:  Joanna J Phillips
Journal:  Oncotarget       Date:  2012-05

Review 5.  Towards understanding the roles of heparan sulfate proteoglycans in Alzheimer's disease.

Authors:  Gan-lin Zhang; Xiao Zhang; Xiao-min Wang; Jin-Ping Li
Journal:  Biomed Res Int       Date:  2014-07-23       Impact factor: 3.411

6.  Heparan Sulfate Biosynthetic System Is Inhibited in Human Glioma Due to EXT1/2 and HS6ST1/2 Down-Regulation.

Authors:  Victor S Ushakov; Alexandra Y Tsidulko; Gabin de La Bourdonnaye; Galina M Kazanskaya; Alexander M Volkov; Roman S Kiselev; Vyacheslav V Kobozev; Diana V Kostromskaya; Alexey S Gaytan; Alexei L Krivoshapkin; Svetlana V Aidagulova; Elvira V Grigorieva
Journal:  Int J Mol Sci       Date:  2017-11-01       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.